Ola Samuelsson

9.2k total citations · 1 hit paper
95 papers, 4.8k citations indexed

About

Ola Samuelsson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ola Samuelsson has authored 95 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 37 papers in Surgery and 37 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ola Samuelsson's work include Lipoproteins and Cardiovascular Health (26 papers), Blood Pressure and Hypertension Studies (24 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Ola Samuelsson is often cited by papers focused on Lipoproteins and Cardiovascular Health (26 papers), Blood Pressure and Hypertension Studies (24 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Ola Samuelsson collaborates with scholars based in Sweden, United States and United Kingdom. Ola Samuelsson's co-authors include Lars Lindholm, Bo Carlberg, Petar Alaupovic, Per‐Ola Attman, Carolyn Knight‐Gibson, Lars Wilhelmsen, Mats Persson, Anders Svensson, P.-O. Attman and Thomas Hedner and has published in prestigious journals such as The Lancet, JAMA and PLoS ONE.

In The Last Decade

Ola Samuelsson

93 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis

2005 618 citations Lars Lindholm, Bo Carlberg et al. profile →

Peers

Ola Samuelsson

CCM

EDM

SURGE

NEPHR

Charles E. Ford United States

José L. Rodicio Spain

Robert A. Phillips United States

Paul Drury United Kingdom

Mátyás Keltai Hungary

Raymond O. Estacio United States

K. H. Rahn Germany

Ole Lederballe‐Pedersen United States

J. Segura Spain

Ronald J. Portman United States

Charles E. Ford United States

Ola Samuelsson

2.9k ×1.2

CCM

1.1k ×0.7

EDM

575 ×0.4

SURGE

943 ×0.8

NEPHR

601 ×1.4

Citations per year, relative to Ola Samuelsson Ola Samuelsson (= 1×) peers Charles E. Ford

Countries citing papers authored by Ola Samuelsson

Since Specialization

Citations

This map shows the geographic impact of Ola Samuelsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Samuelsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Samuelsson more than expected).

Fields of papers citing papers by Ola Samuelsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Samuelsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Samuelsson. The network helps show where Ola Samuelsson may publish in the future.

Co-authorship network of co-authors of Ola Samuelsson

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Samuelsson. A scholar is included among the top collaborators of Ola Samuelsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Samuelsson. Ola Samuelsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gatzinsky, Kliment, et al.. (2020). Repetitive transcranial magnetic stimulation of the primary motor cortex in management of chronic neuropathic pain: a systematic review. Scandinavian Journal of Pain. 21(1). 8–21. 36 indexed citations

Samuelsson, Ola, P.-O. Attman, Ingrid Gause‐Nilsson, Maria Svensson, & Petar Alaupovic. (2013). Dual PPARα/γAgonism Normalizes Lipoprotein Profile of Renal Dyslipidemia. PPAR Research. 2013. 1–7. 3 indexed citations

Ghali, Jalal K., John Wikstrand, Dirk J. van Veldhuisen, et al.. (2008). The Influence of Renal Function on Clinical Outcome and Response to β-Blockade in Systolic Heart Failure: Insights From Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). Journal of Cardiac Failure. 15(4). 310–318. 75 indexed citations

Wilhelmsen, Lars, et al.. (2007). Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. Journal of Hypertension. 25(6). 1311–1317. 87 indexed citations

Lindholm, Lars, Bo Carlberg, & Ola Samuelsson. (2006). Beta blockers in primary hypertension: do age and type of beta-blocker matter?. Journal of Hypertension. 24(11). 2143–2145. 11 indexed citations

Attman, Per-Ola, et al.. (2005). Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia. Nephrology Dialysis Transplantation. 20(9). 1889–1897. 1 indexed citations

Rydberg, Lennart, Anders Bengtsson, Ola Samuelsson, Kurt Nilsson, & Michael E. Breimer. (2004). In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transplant International. 17(11). 666–672. 59 indexed citations

Swärd, Kristina, et al.. (2004). Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial*. Critical Care Medicine. 32(6). 1310–1315. 144 indexed citations

Samuelsson, Ola, Per‐Ola Attman, Rutger Larsson, et al.. (2000). Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. Nephrology Dialysis Transplantation. 15(4). 481–486. 20 indexed citations

10.

Attman, Per-Ola, Ola Samuelsson, James B. Moberly, et al.. (1999). Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis. Kidney International. 55(4). 1536–1542. 60 indexed citations

11.

Moberly, James B., et al.. (1999). Apolipoprotein C-III, Hypertriglyceridemia and Triglyceride-Rich Lipoproteins in Uremia. PubMed. 25(4-6). 258–262. 24 indexed citations

12.

Lindholm, Lars & Ola Samuelsson. (1998). [Treatment of high blood pressure still unchanged. Diuretics and beta-blockaders are first choice preparations].. PubMed. 95(7). 648–51. 1 indexed citations

13.

Andersson, O, et al.. (1998). Survival in treated hypertension: follow up study after two decades. BMJ. 317(7152). 167–171. 147 indexed citations

14.

Samuelsson, Ola, Kjell Pennert, O Andersson, et al.. (1996). Diabetes mellitus and raised serum triglyceride concentration in treated hypertension—are they of prognostic importance? Observational study. BMJ. 313(7058). 660–663. 33 indexed citations

15.

Samuelsson, Ola, Thomas Hedner, G Berglund, et al.. (1994). Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden.. PubMed. 8(4). 257–63. 55 indexed citations

16.

Samuelsson, Ola, et al.. (1994). The role of diabetes mellitus and hypertriglyceridaemia as coronary risk factors in treated hypertension: 15 years of follow‐up of antihypertensive treatment in middle‐aged men in the Primary Prevention Trial in Göteborg, Sweden. Journal of Internal Medicine. 235(3). 217–227. 8 indexed citations

17.

Lunde, Helen, et al.. (1994). Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ. 308(6920). 18–18. 50 indexed citations

18.

Agewall, Stefan, et al.. (1993). Microalbuminuria in treated hypertensive men at high risk of coronary disease. Journal of Hypertension. 11(4). 461–469. 53 indexed citations

19.

Samuelsson, Ola, Thomas Hedner, Susanne Ljungman, et al.. (1992). A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension. European Journal of Clinical Pharmacology. 43(5). 469–475. 5 indexed citations

20.

Samuelsson, Ola, Marianne Hartford, Lars Wilhelmsen, G Berglund, & John Wikstrand. (1989). Radiological heart enlargement in treated hypertensive men: a comparative study of chest X‐ray examination and M‐mode echocardiography. Journal of Internal Medicine. 225(2). 77–83. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact